Table of Contents
Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective procedures. The Nuclear Medicine has been witnessing a steady demand over the past few years, backed by the worldwide increase in the number of cancer and cardiovascular cases, increasing awareness about early disease detection, and an ever increasing ageing population.
According to our research report, "Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at a CAGR of 9.1% during the forecasted period (2014 to 2020). The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.
Our segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.
Our report has been authored to evaluate the Global Nuclear Medicine market potentials, and identify future growth opportunities. It provides extensive research and analysis on major factors propelling the growth of the industry, challenges holding back the industry, and latest trends and developments in the market.
The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The global nuclear medicine equipment market is expected to reach a value of USD 2.7 billion by 2025, according to a new report by Grand View Research, Inc. Nuclear medicine involves the utilization of ...
The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2021. Nuclear medicine utilizes the radioisotope for application ...
The Global Nuclear Medicine is poised to grow at a CAGR of around 10.2% over the next decade to reach approximately $11.3 billion by 2025. Some of the prominent trends that the market is witnessing include ...